- Home
- GRDN vs CERT Comparison
GRDN vs CERT Comparison
Compare GRDN & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRDN
- CERT
- Stock Information
- Founded
- GRDN 2004
- CERT 2008
- Country
- GRDN United States
- CERT United States
- Employees
- GRDN N/A
- CERT N/A
- Industry
- GRDN Retail-Drug Stores and Proprietary Stores
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- GRDN Consumer Staples
- CERT Technology
- Exchange
- GRDN Nasdaq
- CERT Nasdaq
- Market Cap
- GRDN 1.6B
- CERT 1.9B
- IPO Year
- GRDN 2024
- CERT 2020
- Fundamental
- Price
- GRDN $20.50
- CERT $11.15
- Analyst Decision
- GRDN Strong Buy
- CERT Buy
- Analyst Count
- GRDN 2
- CERT 7
- Target Price
- GRDN $24.50
- CERT $15.67
- AVG Volume (30 Days)
- GRDN 267.8K
- CERT 2.0M
- Earning Date
- GRDN 08-15-2025
- CERT 08-06-2025
- Dividend Yield
- GRDN N/A
- CERT N/A
- EPS Growth
- GRDN N/A
- CERT N/A
- EPS
- GRDN N/A
- CERT N/A
- Revenue
- GRDN $1,282,307,000.00
- CERT $394,498,000.00
- Revenue This Year
- GRDN $12.01
- CERT $11.57
- Revenue Next Year
- GRDN $2.33
- CERT $8.93
- P/E Ratio
- GRDN N/A
- CERT N/A
- Revenue Growth
- GRDN 19.55
- CERT 9.37
- 52 Week Low
- GRDN $14.16
- CERT $8.64
- 52 Week High
- GRDN $26.91
- CERT $16.93
- Technical
- Relative Strength Index (RSI)
- GRDN N/A
- CERT 46.88
- Support Level
- GRDN N/A
- CERT $10.83
- Resistance Level
- GRDN N/A
- CERT $11.71
- Average True Range (ATR)
- GRDN 0.00
- CERT 0.44
- MACD
- GRDN 0.00
- CERT 0.05
- Stochastic Oscillator
- GRDN 0.00
- CERT 52.52
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.